Schedule-dependent drug effects of oral 5-lodo-2-pyrimidinone-2'-deoxyribose as an in vivo radiosensitizer in U251 human glioblastoma xenograftsSEO, Yuji; TAOYAN; SCHUPP, Jane E et al.Clinical cancer research. 2005, Vol 11, Num 20, pp 7499-7507, issn 1078-0432, 9 p.Article

Uterine Cervical Cancer Displaying Tumor-Related Leukocytosis: A Distinct Clinical Entity With Radioresistant FeatureMABUCHI, Seiji; MATSUMOTO, Yuri; HAYASHI, Masami et al.Journal of the National Cancer Institute. 2014, Vol 106, Num 7, issn 0027-8874, dju147.1-dju147.11Article